StreetInsider.com News Articles

Form 4 CARLSMED, INC. For: Mar 02 Filed by: Cordonnier Michael

Wed, 04 Mar 2026 16:05:00 +0000

si-local-file:///var/storage/secattach/20260304/26110956.html

Form 4 CARLSMED, INC. For: Mar 02 Filed by: Cordonnier Michael

Wed, 04 Mar 2026 16:05:00 +0000

si-local-file:///var/storage/secattach/20260304/26110956.html

Form 144 CARLSMED, INC. Filed by: Cordonnier Michael

Mon, 02 Mar 2026 16:54:00 +0000

si-local-file:///var/storage/secattach/20260302/26093337.html

Form 144 CARLSMED, INC. Filed by: Cordonnier Michael

Mon, 02 Mar 2026 16:54:00 +0000

si-local-file:///var/storage/secattach/20260302/26093337.html

Carlsmed, Inc. (CARL) Tops Q4 EPS by 3c

Thu, 26 Feb 2026 02:45:50 +0000

Carlsmed, Inc. (NASDAQ: CARL) reported Q4 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.9 million.

For earnings history and earnings-related data on Carlsmed, Inc. (CARL) click here.

Form S-8 CARLSMED, INC.

Wed, 25 Feb 2026 16:16:00 +0000

si-local-file:///var/storage/secattach/20260225/26060226.html

Form S-8 CARLSMED, INC.

Wed, 25 Feb 2026 16:16:00 +0000

si-local-file:///var/storage/secattach/20260225/26060226.html

Form 10-K CARLSMED, INC. For: Dec 31

Wed, 25 Feb 2026 16:10:00 +0000

si-local-file:///var/storage/secattach/20260225/26059978.html

Form 10-K CARLSMED, INC. For: Dec 31

Wed, 25 Feb 2026 16:10:00 +0000

si-local-file:///var/storage/secattach/20260225/26059978.html

Form 8-K CARLSMED, INC. For: Feb 25

Wed, 25 Feb 2026 16:06:00 +0000

si-local-file:///var/storage/secattach/20260225/26059794.html

Form 8-K CARLSMED, INC. For: Feb 25

Wed, 25 Feb 2026 16:06:00 +0000

si-local-file:///var/storage/secattach/20260225/26059794.html

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Wed, 25 Feb 2026 16:01:00 +0000

Fourth quarter revenue of $15.2 million; 61% growth YoY

Full year revenue of $50.5 million; 86% growth YoY

CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

"We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%, and reduction of our lead times to within six business days. These achievements demonstrate our momentum and the

Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

Wed, 25 Feb 2026 16:01:00 +0000

Fourth quarter revenue of $15.2 million; 61% growth YoY

Full year revenue of $50.5 million; 86% growth YoY

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference